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Objective: Patients in rehabilitation with comorbid depres-
sive disorders display increased morbidity, mortality and 
inability to work. The aim of this study is to determine the 
prevalence of comorbid depressive symptoms in rehabilita-
tion.
Methods: A total of 6,000 patients were contacted by post at 
the same time as receiving approval for their medical reha-
bilitation from German Federal Pension Insurance. Depres-
sive symptoms were assessed using the Patient Health Ques-
tionnaire (PHQ-2). Results were compared with prevalences 
in the general population by analysing the German Health 
Interview and Examination Survey for Adults (DEGS).
Results: A total of 2,152 out of 5,891 patients participated 
in the study (response rate: 36.5%). The prevalence of self-
reported depressive symptoms was 33.1% (women 34.1%, 
men 31.3%). In contrast, 7.8% of the German general pop-
ulation reported depressive symptoms (women 9.4%, men 
6.2%). The highest prevalences were found in neurological 
(36.4%) and orthopaedic (35.6%) rehabilitation, the lowest 
in cancer rehabilitation (23.0%). Depressive symptoms were 
significantly associated with higher comorbidity and impair-
ment due to pain, with lower social support and self-efficacy 
and with specific work-related problems.
Conclusion: A short routine screening yielded a positive test 
result for depressive symptoms in a third of rehabilitation 
patients, thus approximately four times higher than in the 
general population. This is valuable information in order to 
better adjust treatment to patient needs. 
Key words: comorbidity; depression; self-assessment; rehabili-
tation; screening; cross-sectional studies.
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INTRODUCTION
Medical rehabilitation follows a multidisciplinary approach 
based on the International Classification of Functioning, 
Disability and Health (ICF) and its bio-psycho-social model 
of illness. Rehabilitation should tackle the patient’s possible 
multimorbidity. In this context, comorbid mental disorders play 
a decisive role. An adverse effect of comorbid depressive dis-
orders on the individual’s health and the social security system 
has been shown in numerous studies. Depressive comorbidity 
is associated with lower quality of life (1), increased utilization 
of healthcare benefits, and higher rates of long term sick-leave 
(2). The number of additional diseases is higher in the presence 
of depressive comorbidity, and mortality risk is increased (3).
Cancer, cardiac and diabetic patients are hospitalized for a 
prolonged period of time if they additionally have mental co-
morbidity (3). Depressive comorbidity is also associated with 
increased costs of medical care (4), an increased issuing of medi-
cal certificates (5), and a higher rate of disability pensions (6).
Numerous prevalence studies of mental disorders were 
conducted within the general population, many of them under 
the umbrella of the World Mental Health Survey Initiative 
(7). Other studies deal with the epidemiology of depressive 
disorders as a comorbidity of different somatic diseases, such 
as arthritis (8), chronic back pain (9), heart disease (10), dia-
betes (11) and multiple sclerosis (12). Reported odds ratios 
range from 1.4 to 2.3 for major depression and 1.3 to 2.8 for 
dysthymia compared with healthy individuals. These study 
participants were not, however, recruited in rehabilitation 
settings but from the general population.
The comorbidity of depression within different fields of reha-
bilitation, such as cardiology and oncology, remains uncertain. 
This is surprising, since depression is widespread within the 
general population and its adverse health effects are well known. 
A prevalence estimation of depressive comorbidity could facili-
tate a more precise planning of requirements in rehabilitation 
facilities, and thus improve the therapy and recovery of patients. 
Härter et al. reported a point prevalence of 12.3% for depressive 
symptoms in rehabilitation. This study was, however, performed 
in non-randomly selected single inpatient facilities within only 
one region in Germany (13). Therefore, these results cannot be 
considered as representative on a nationwide level.
For these reasons, the aim of this work is to determine the 
prevalence of comorbid depressive symptoms in rehabilitation 
patients across all major disease groups in a nationwide study 
in Germany. In addition, it aims to examine the association of 
self-reported depressive symptoms with other impairments and 
resources relevant for rehabilitation. A comparison with the 
German general population will be provided based on analyses 
of the German Health Interview and Examination Survey for 
Adults (DEGS).
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METHODS
Study design
A nationwide observational study was conducted in Germany. A total 
of 6,000 persons insured with the Deutsche Rentenversicherung Bund 
(German Federal Pension Insurance) were contacted by post and asked 
to complete a questionnaire at the same time as they received approval 
for their medical rehabilitation (between September and November 
2011). Patients were included in the study based on approval for their 
medical rehabilitation according to §15 SGB VI (German social security 
code). These are rehabilitations with the aim of securing or restoring the 
ability to work. In Germany, rehabilitation follows a multidisciplinary 
and multimodal approach that usually lasts 3 weeks in full-time care, 
although an optional additional week can be requested. Rehabilitation 
patients are treated in specialized inpatient or outpatient facilities that 
focus on 1 or more fields of rehabilitation defined by disease groups. 
Patients who were treated in the 6 most common disease groups were 
included in the study. These disease groups are: musculoskeletal dis-
eases (admission diagnosis according to the International Classification 
of Diseases ICD-10: M00–M99), diseases of the circulatory system 
(I00–I99), gastrointestinal, endocrine, nutritional and metabolic diseases 
(E00–E90, K00–K93), diseases of the respiratory system (J00–J99), 
neoplasms (C00–D48), and diseases of the nervous system (G00–G99). 
The questionnaire had to be completed prior to the start of rehabilitation 
to rule out effects of the medical rehabilitation on the response.
To allow separate evaluations according to disease groups, random 
sampling was conducted in combination with stratification according 
to disease groups of 1,000 insured people each. Within these 6 disease 
groups the most common diseases include chronic back pain (M50–
M54), stroke (I61–I64), coronary heart disease (I20–I25), hypertension 
(I10–I15), diabetes (E10–E14), asthma (J45), breast cancer (C50) and 
multiple sclerosis (G35) (14). The chosen sample size allows us to 
determine the prevalence of depressive symptoms with a confidence 
level of ± 5 percentage points at the level of single disease groups and 
of ± 2 percentage points for the combined sample, assuming a response 
rate of 32% and a prevalence of 30%.
Data collection and instruments
Depressive symptoms were measured using the short version of the 
Patient Health Questionnaire (PHQ-2) (15). The PHQ-2 is based on the 2 
key diagnostic criteria for depressive disorders according to Diagnostic 
and Statistical Manual (DSM-IV). It allows us to assess both “little 
interest or pleasure in doing things” and “feeling down, depressed, or 
hopeless”, on 4-point Likert scales referring to a period of the 2 previous 
weeks. Depressive symptomatology is defined as a total PHQ-2 score of 
at least 3 points, while the instrument ranges between 0 and 6 points (15).
To include additional impairments and resources relevant for 
rehabilitation, further instruments were used (16): comorbidity was 
examined using the Self-Administered Comorbidity Questionnaire 
(SCQ) (17), impairment due to pain using the Pain Disability Index 
(PDI) (18), social support with a scale composed of the Indicators of 
Rehabilitation Status Questionnaire (IRES) (19), self-efficacy using 
the General Self-Efficacy Scale (GSE) (20), and specific work-related 
problems using the short version of the Screening Instrument for De-
tecting the Need of Work-Related Medical Rehabilitation (SIMBO) 
(21). For 90.8% of the participants we could link the assessment data 
with sociodemographic variables and medical history data concerning 
the rehabilitation (by using data from their insurance account). What-
ever the reasons, we assume that a large part of the remaining 9.2% 
of participants did not start their granted medical rehabilitation (22).
Approval was obtained from the ethics committee of the Charité – 
Universitätsmedizin Berlin for these analyses. All participants gave 
written informed consent to participate in the study.
Data analyses
As the rate of missing data across all the scales was as low as 7.4%, 
only participants providing a complete record in terms of the assess-
ment data were included. At first, the non-responses were analysed 
for essential sociodemographic variables on the basis of χ2 and Mann-
Whitney U tests. We established weighting factors to improve the 
accuracy of the prevalence estimation. These weights account for the 
varying willingness to participate between men and women and for 
deviations in the drawn sample that occurred when compared with the 
sex distribution in rehabilitation in 2011. Due to the stratified sampling, 
cross-indication analyses were additionally weighted according to the 
distribution of disease groups in 2011 (14).
Prevalences of self-reported depressive symptoms and their 95% 
confidence intervals (95% CI) are reported for all rehabilitation 
patients, and stratified for sex, age and disease groups. Three age cat-
egories of approximately equal size were established (20–44, 45–54 
and 55–65 years) and a χ2 test was performed to assess a linear trend. 
To examine the association of depressive symptoms with other impair-
ments and resources relevant for rehabilitation we built a logistic regres-
sion model with controls for sex, age, and their interaction. The binary 
dependent variable was depressive symptomatology, the other reported 
instruments served as continuous independent variables. The SIMBO was 
factored in as binary independent variable (specific work-related problem 
present vs not present). The significance level was defined as α = 0.05. 
The analyses were computed with the SPSS version 23 (IBM Corp.).
Additional analyses
To compare prevalences of depression in rehabilitation with the preva-
lence in the general population, the public use file of the DEGS was also 
analysed according to the PHQ-2 (23). The study design, response, weight-
ing, and core characteristics of the sample are described elsewhere (24). 
RESULTS
Prevalence of comorbid depressive symptoms in rehabilitation 
patients
Table I characterizes the study population. Of the 5,891 individu-
als who were successfully contacted and who met the inclusion 
criteria, 2,152 participated in the study (response rate 36.5%) 
(Fig. 1). In the complete case analyses there were 305–365 
patients per disease group, and 1,992 participants overall.
The mean age of all participants was 50.4 years (standard 
deviation (SD) 8.3) (range 20–65 years). Almost two-thirds 
were women. Twenty percent of participants had no periods 
of inability to work, and the remaining participants had been 
unable to work for less than 3 months (48.1%), 3 to under 6 
months (10.4%), or at least 6 months (16.7%) during the 12 
months prior to rehabilitation. Of all participants, 4.7% reg-
istered as unemployed. 
The de facto duration of rehabilitation was on mean 3 days 
longer than approved duration of rehabilitation (25.1 (SD 
5.6) vs. 22.0 days (SD 3.1)). The non-response analyses did 
not reveal any significant differences between the included 
participants and the remaining sample in terms of all examined 
sociodemographic variables and rehabilitation details (Table I).
The prevalence of comorbid self-reported depressive 
symptoms was 33.1% (95% confidence interval (95% CI): 
31.1–35.2). In women, the proportion was 34.1% (95% CI: 
31.6–36.6), and thus numerically, but not significantly, higher 
than in men (31.3%; 95% CI: 27.7–35.1). The stratification 
according to age categories indicated a significant gradient 
(p = 0.038). The highest prevalence of depressive symptoms 
was found among rehabilitation patients under 45 years of age, 
revealing a proportion of 37.8% (95% CI: 33.0–42.6). Patients 
aged 55–65 years formed the group with the lowest proportion 
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of depressive symptoms (31.2% (95% CI: 27.8–34.6)) (Fig. 2).
Analyses according to disease groups showed the lowest 
prevalence of depressive symptomatology in cancer rehabilita-
tion (23.0%; 95% CI: 18.7–27.3). The percentages were highest 
in neurological (36.4%; 95% CI: 31.1–41.8) and orthopaedic 
rehabilitation (35.6%; 95% CI: 30.4–40.7). In rehabilitation of 
patients with diseases of the circulatory or respiratory system and 
with gastrointestinal, endocrine, nutritional or metabolic diseases, 
the mean prevalences ranged from 29.6% to 33.1% (Fig. 3).
The regression model showed that depressive symp-
toms are significantly associated with higher comorbidity 
(OR = 1.09; 95% CI: 1.06–1.12) and higher impairment due 
to pain (OR = 1.05; 95% CI: 1.04–1.06), lower social support 
(OR = 0.94; 95% CI: 0.92–0.96), lower expectations of self-
efficacy (OR = 0.91; 95% CI: 0.87–0.95) as well as with the 
presence of specific work-related problems (OR = 1.36; 95% 
CI: 1.08–1.71) (Table II).
Table I. Description and comparison of included study participants and the remaining sample
Sociodemographic characteristics and rehabilitation details 










Age, years, mean (SD) 1,992 50.4 (8.3) 3,899 49.6 (9.5) 0.069
Sex, % 
  Women
   Men
1,313









  Urban regions
  Regions with urbanization














Unemployed, %   73   4.0   171   4.9 0.141
Inability to work 12 months prior to rehabilitation, %
  6–12 months 
  3 to under 6 months
  Under 3 months 
  None




















  5.7 
0.104
Disease groups (weighting factorsb), %
  Musculoskeletal diseases (3.67)
  Diseases of the circulatory system (0.47)
  Gastrointestinal and endocrine diseases (0.33)
  Diseases of the respiratory system (0.44)
  Neoplasms (0.69)


























Approved duration of rehabilitation, days, mean (SD) 1,962 22.0 (3.1) 3,713 21.9 (3.5) 0.060
De facto duration of rehabilitation, days, mean (SD) 1,809 25.1 (5.6) 3,298 25.0 (6.2) 0.170
aClassification according to the German Federal Institute for Research on Building, Urban Affairs and Spatial Development. bWeighting factors for 
distribution of sex and disease groups in medical treatment rehabilitations provided by the German Federal Pension Insurance 2011 (14). 
SD: standard deviation.
Fig. 1. Study participants.
Gross sample (n=6,000) 
Net sample (n=5,891) 
Study participants (n=2,152) 
Complete case analysis (n=1,992) 
Could not be reached by mail (n=109) 
Did not respond or responded after 
start of rehabilitation (n=3,739)   
Participants with missing data (n=160) 
Fig. 2. Prevalence of comorbid depressive symptoms in rehabilitation 
patients stratified by sex and age (with 95% confidence intervals, n = 1,992). 
Weighted for disease groups in medical treatment rehabilitations provided 
by the German Federal Pension Insurance 2011, cross-gender analyses 
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Prevalence of depressive symptoms in the general population
Out of 5,938 persons aged 18–64 years who are enlisted in 
the DEGS, those 98% with complete PHQ-2 data-sets were 
included in the analyses of the public use file. Overall, the 
prevalence of self-reported depressive symptoms was 7.8% 
(95% CI: 7.0–8.7). Women had a significantly elevated preva-
lence of 9.4% (95% CI: 8.2–10.8) compared with the men’s 
prevalence of 6.2% (95% CI: 5.3–7.3).
Mean prevalences were approximately 7% or 8% for each 
of the age groups; 8.0% for 18–44-year-old individuals (95% 
CI: 6.9–9.4), 7.3% for 45–54-year-olds (95% CI: 5.8–9.2), and 
7.7% for 55–64-year-olds (95% CI: 5.8–10.1).
DISCUSSION
Approximately one-third of patients in rehabilitation were as-
sessed as having depressive symptoms according to the PHQ-2. 
Therefore, the proportion of people with depressive symptoms is 
increased by a factor of approximately 4 in rehabilitation com-
pared with the prevalence in the general population. A prevalence 
of 8.1% with depressive symptoms in the general population was 
ascertained in the DEGS (25). A marginally lower prevalence 
of 7.8% was found in our analyses of self-reported depressive 
symptoms within the DEGS by using the short version of the 
PHQ-2 instead of its original instrument PHQ-9. This is in ac-
cordance with a study comparing different instruments measur-
ing depression, including PHQ-2 and PHQ-9 (26). 
Gender differences were not statistically significant in reha-
bilitation despite the fact that in the general population women 
have a higher risk of depression than men (9.4% of women 
vs 6.2% of men show depressive symptoms). Higher rates of 
depressive symptoms in women and in younger patients are 
in accordance with other surveys (25). 
The particularly high prevalences in orthopaedic and neuro-
logical rehabilitation seem plausible. In fact, the most frequent 
diagnoses in these areas of rehabilitation are chronic back 
pain and multiple sclerosis (14). For these 2 diagnoses, a high 
prevalence of depressive comorbidity has been described in 
epidemiological population-based studies (9, 12). The significant 
correlation between depressive symptoms and other exam-
ined impairments and resources confirms preliminary studies 
(27–31). In this study, the prevalence of self-reported depres-
sive symptoms in rehabilitation was examined for the first time 
based on a nationwide data collection. Another German study 
was conducted in single rehabilitation hospitals between 1998 
and 2004, reporting a point prevalence of 12.3% for depressive 
symptoms (13). Due to the selective sampling in single inpatient 
facilities confined to a certain region only, the results cannot, 
however, be considered as representative. Moreover, they used 
different instruments from the ones in our study. It therefore 
remains uncertain whether the identified differences in preva-
lences are due only to methodological reasons or reflect reality. 
Strengths and limitations of the study
In our study, we depict medical rehabilitation throughout Ger-
many across all essential disease groups. Inpatient, as well as 
outpatient, rehabilitation settings were included. The 6 disease 
groups that were included represent a total of 95.7% of all re-
habilitation measures realized by the German Federal Pension 
Insurance (excluding rehabilitation due to mental disorders) 
(14). The stratified study design allowed additional evalua-
tions for single disease groups. The response rate of 36.5% is 
comparable with other epidemiological studies (32). Due to 
the limited time between approval and start of rehabilitation it 
was not possible to send out follow-up letters. The extensive 
non-response analyses based on sociodemographic data and 
duration of rehabilitation did not provide an indication for a 
relevant selection bias (Table I). For the cross-gender analy-
ses, the slight variation in willingness to participate between 
Table II. Association of depressive symptoms and other impairments 
and resources relevant for rehabilitation
Instruments (range) OR (95% CI) p-value
Constant 0.32 0.066
Comorbidity SCQ (0–39) 1.09 (1.06–1.12) < 0.001
Impairment due to pain PDI (0–70) 1.05 (1.04–1.06) < 0.001
Self-efficacy GSE (10–40) 0.94 (0.92–0.96) < 0.001
Social support IRES (0–10) 0.91 (0.87–0.95) < 0.001
Specific work-related problems
  SIMBO (yes/no) 1.36 (1.08–1.71) 0.009
Multivariate binary logistic regression adjusted for age, sex and its 
interaction; reciprocally adjusted effects of stated impairments and 
resources (n = 1,992). Corrected r2=0.293. Weighted for distribution of 
sex and disease groups in medical treatment rehabilitations provided by 
the German Federal Pension Insurance 2011 (14).
95% CI: 95% confidence interval; GSE: General Self-Efficacy Scale; 
IRES: Indicators of Rehabilitation Status Questionnaire; OR: odds 
ratio; PDI: Pain Disability Index; SCQ: Self-Administered Comorbidity 
Questionnaire; SIMBO: Screening Instrument for Detecting the Need of 
Work-Related Medical Rehabilitation.
Fig. 3. Prevalence of comorbid depressive symptoms in rehabilitation 
patients stratified by disease groups (with 95% confidence intervals, 
n = 1,992). Weighted for distribution of sex in medical treatment 
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men and women was factored in correspondingly. Additional 
analyses, which compare participants with the remaining 
sample with regard to rehabilitation variables that are signifi-
cantly related to the presence of depressive symptoms, also 
did not show any significant differences (data not shown). This 
includes the amount of psychotherapeutic therapy during the 
rehabilitation, reduced psychological resilience, and the recom-
mendation for a psychological counselling or treatment after 
rehabilitation by the responsible physician or psychologist at 
the end of rehabilitation. Selection bias cannot be ruled out 
completely, but there is no evidence for substantial selection 
bias. Nevertheless, both a higher as well as a lower prevalence 
of depressive symptoms is possible. 
In terms of generalizability it must be considered that the 
results cannot necessarily be transferred to so-called follow-up 
rehabilitation into which patients are moved directly from a 
hospital. Follow-up rehabilitation may be applied, for example, 
in patients having had an implantation of an endoprosthesis 
or chemotherapeutic treatment. The limitation of this study to 
conventional medical rehabilitations might also explain why 
the prevalence of depressive symptoms was less elevated in 
cancer rehabilitation compared with the other disease groups. 
We believe that this is because usually approximately one year 
passes from the time when cancer was diagnosed until one 
enters a non-follow-up rehabilitation, which is a considerable 
period of time for adapting to normal life. The exclusion of 
follow-up rehabilitations resulted from the differing application 
procedure and the insurants’ accessibility via the post (14).
We are aware of the limitations of this study, which arise 
due to the method of recruitment of patients. The German 
Federal Pension Insurance is by far the largest payer of medi-
cal rehabilitation; it insures approximately 34 million people 
(out of a total of 81 million citizens in Germany) and realizes 
approximately 450,000 medical rehabilitations per year (14). 
Nonetheless, the results cannot be transferred uncondition-
ally to rehabilitation patients sponsored by other payers. This 
applies in particular to the statutory health insurance, which 
is primarily responsible for rehabilitations realized at post-
working age, while the German Pension Insurance focuses on 
rehabilitation for the working-age population.
Another limitation could be that our measurement is a scale 
of self-reported depressive symptoms. It has to be emphasized 
that PHQ-2 does not deliver a diagnosis of clinical depression. 
According to a validation study, PHQ-2 provides a sensitivity of 
depressive disorders of 79% and a specificity of 86% (15). PHQ-2 
has a similar diagnostic accuracy as other self-evaluation instru-
ments, such as PHQ-9 and the Hospital Anxiety and Depression 
Scale (HADS) (33, 34). PHQ-2 can be applied as a first-stage 
screening instrument, but further diagnostic steps should follow. 
Conclusion
The prevalence of comorbid depressive symptoms in rehabilita-
tion is 33.1%; approximately 4 times higher than in the German 
general population. A significant association of depressive 
symptoms with impairment due to pain, specific work-related 
problems, a higher comorbidity score, lower self-efficacy and 
lower social support was observed. Thus, a routine depression 
screening of all rehabilitation patients seems appropriate, since 
depressive impairments in rehabilitation seem to have a substan-
tial prevalence. Patients could benefit if treated appropriately, 
since mental comorbidity can have adverse effects on rehabilita-
tion outcomes (35). The German Pension Insurance developed 
recommendations for a screening of mental comorbidity in 
rehabilitation facilities (36). A corresponding screening for 
psychological symptoms implemented already into the applica-
tion process for medical rehabilitation could improve the future 
distribution to suitable rehabilitation facilities offering specific 
and well-structured treatment concepts customized to patients 
with mental comorbidity. In some orthopaedic and cardiac reha-
bilitation facilities in particular, these structured and prolonged 
(4 weeks in full-time) behavioural-medical rehabilitation pro-
grammes have already been established (37). In addition, there 
are practical recommendations for psychological interventions 
in multidisciplinary rehabilitation concerning various somatic 
diseases (38, 39). The concept of medical rehabilitation in 
Germany is based on the ICF and its bio-psycho-social model. 
It offers a solid general framework of integrated rehabilitation 
care for somatic and mental impairment. Systematic reviews 
support that multidisciplinary rehabilitation including psycho-
logical interventions improves patient outcomes, e.g. concerning 
chronic low back pain (40).
In Germany, the payer is responsible both for the approval 
of a medical rehabilitation and for selecting an appropriate 
inpatient or outpatient rehabilitation facility (based on ap-
plication documents). Unlike, for example, for work-related 
impairments, self-evaluation instruments for the assessment of 
depressive symptoms, such as the Patient Health Questionnaire, 
have not yet been implemented routinely into the application 
documents. A screening for mental comorbidities could pro-
vide the payer with information about a potential comorbid 
mental impairment when a suitable rehabilitation facility is 
needed. An economic screening instrument is available with, 
for example, the PHQ-2 (33). A more differentiated allocation 
to rehabilitation facilities corresponding to the patient’s impair-
ment situation could potentially lead to a more needs-oriented 
care in medical rehabilitation.
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